The hedge fund Elliott Management will attempt to block McKesson's offer to acquire the German pharmaceutical wholesaler Celesio because it “substantially undervalues” the company, according to a report in the New York Times published Tuesday.
An expert panel at the Food and Drug Administration has given a thumbs-up to an experimental drug made by Takeda Pharmaceutical Co. for treating ulcerative colitis and Crohn's disease, the drug maker said.
Personalized medicine is on the horizon, and patients are not only awaiting it optimistically, but they also are willing to share a bit of personal information when it comes, according to a new study released Monday commissioned by Intel.
The natural personal care market continues to see strong growth, posting healthy double-digit gains globally with Brazil and China taking the lead as the fastest-growing natural personal care markets, according to consulting and research firm Kline & Co.
Lt. Gov. Ron Ramsey, Tennessee Rep. Tony Shipley, R-Kingsport along with representatives from Food City and the Consumer Healthcare Products Association, announced the expansion of Tennessee's statewide Anti-Smurfing Campaign.
Teva Pharmaceutical Industries anticipates that it could lose about $500 million in sales next year if a generic version of its multiple sclerosis drug hits the market, the Israeli drug maker said Tuesday.